Delivery Order SPE2DX22D0010-SPE2D826FAG75
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,440 on September 18, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price contract, with an ultimate completion date of September 19, 2025, represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $1,247.80 by the Defense Logistics Agency's Medical Supply Chain on September 8, 2025. This competitively awarded, firm fixed-price delivery order is unset-aside and has an ultimate completion date of September 9, 2025. The contract represents a child order issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $87,087.90 on October 8, 2025, by the Defense Logistics Agency's Medical Supply Chain. This competitively awarded, firm fixed-price contract carries an ultimate completion date of October 9, 2025, and represents a non-set-aside procurement. The award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $5,045.04 by the Defense Logistics Agency's Medical Supply Chain on August 17, 2025. This non-competitive delivery order represents a firm fixed price contract with an ultimate completion date of August 18, 2025, and is classified as a child contract under a larger indefinite delivery vehicle. The award demonstrates AmerisourceBergen's continued role...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $3,076.25 by the Defense Logistics Agency's Medical Supply Chain on October 1, 2025, with an ultimate completion date of October 2, 2025. This firm fixed-price delivery order represents a non-set-aside, competitively awarded contract and serves as a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX,...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $13,788.50 by the Defense Logistics Agency's Medical Supply Chain on September 29, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by September 30, 2025. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $19,199.96 on October 6, 2025, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed price contract, which is not set-aside and competitively awarded, is scheduled for completion by October 7, 2025. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $85,137.01 by the Defense Logistics Agency's Medical Supply Chain on October 13, 2025. This non-competed, firm fixed-price delivery order is expected to be completed by October 14, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical valued at $999,999,999.00 and...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $519,807.48 on September 10, 2025, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price delivery order, with an ultimate completion date of September 11, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $247,197.12 by the Defense Logistics Agency's Medical Supply Chain on September 29, 2025. This firm fixed-price delivery order, with completion scheduled for September 30, 2025, represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award is...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D826FAG75Delivery Order
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,036.80 on October 12, 2025, by the Defense Logistics Agency Medical Supply Chain. This firm fixed-price contract, which is a child award under a larger indefinite delivery contract vehicle, requires completion by October 14, 2025. The award was competitively procured without set-aside designation and represents a continuation of AmerisourceBergen's role as a critical pharmaceutical distributor to federal military and veteran healthcare systems. This delivery order is executed under AmerisourceBergen's prime Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent contract serves as a comprehensive pharmaceutical support vehicle enabling AmerisourceBergen to supply an extensive range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs globally. The company's substantial federal contract portfolio demonstrates its proven capability to deliver diverse pharmaceutical products across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through this flexible contracting mechanism.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 10/12/25 |